Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News

Ensitrelvir Reduces COVID Risk Among Contacts Post-Exposure

Household contacts who initiate ensitrelvir vs placebo within 72 hours of symptom onset in the index patient have lower risk of developing COVID, with no apparent safety concerns.

Anemia Leads List of Factors That Affect BLVR Failure

Recognizing the impact of comorbidities may guide patient selection and improve outcomes.

How to Teach Professionalism? Ditch the Deficiency Focus

Teaching professionalism in medical school is required, but how best to do it? Move beyond a deficiency focus, experts say. Emphasize positive examples of professionalism.

Paid Parental Leave for Med School Faculty Often Lacking

Many medical schools don’t offer nationally recommended levels of paid parental leave.

Congo's Ebola Outbreak Spreads to Two More Provinces

The Ebola outbreak in the Democratic Republic of Congo has spread to two more northeastern provinces, Haut-Uele ⁠and Tshopo, the country's public health institute said in...

‘Super Movers’ May Have Slower Cognitive Decline

Fast-walking ‘super movers’ aged 80 years or older have about half the risk for cognitive impairment but no less Alzheimer’s disease pathology.

Todays Updates

An Oral Ketamine Drug for Depression — Minus the Trip?

A novel oral ketamine drug shows a signal for reducing depressive symptoms with minimal dissociative effects.

Info on Risk for Prostate Cancer Spurs Decision-Making

Men who receive personalized estimates of the likelihood of raised prostate-specific antigen levels are more likely to decide to get screening than those who receive general information on pros and cons.

Fast Symptom Relief in Ulcerative Colitis: Which Rx Wins?

Upadacitinib and infliximab offer rapid relief from symptoms in biologic-naive patients with moderate-to-severe ulcerative colitis.

Europe’s AI Reality: Practice Outpaces Policy and Reviews

Clinicians and patients are already relying on AI, while hospitals are still building the oversight to keep up.

Cognitive Benefit of Healthy Living Confirmed: LatAm-FINGERS

A culturally tailored lifestyle program improves cognition significantly more than standard health advice among older adults at risk for dementia across Latin America.

Health Issues Tied to Behaviours in Intellectual Disability

People with intellectual disabilities who have physical health problems or sensory impairments face a higher risk for challenging behaviours.

Rimegepant Effective in Treatment-Resistant Migraine

Rimegepant is safe and effective in patients with migraine not responding to multiple prior preventive therapies, a real-world study shows.

Todays Updates

An Oral Ketamine Drug for Depression — Minus the Trip?

A novel oral ketamine drug shows a signal for reducing depressive symptoms with minimal dissociative effects.

Info on Risk for Prostate Cancer Spurs Decision-Making

Men who receive personalized estimates of the likelihood of raised prostate-specific antigen levels are more likely to decide to get screening than those who receive general information on pros and cons.

Fast Symptom Relief in Ulcerative Colitis: Which Rx Wins?

Upadacitinib and infliximab offer rapid relief from symptoms in biologic-naive patients with moderate-to-severe ulcerative colitis.

Europe’s AI Reality: Practice Outpaces Policy and Reviews

Clinicians and patients are already relying on AI, while hospitals are still building the oversight to keep up.

Cognitive Benefit of Healthy Living Confirmed: LatAm-FINGERS

A culturally tailored lifestyle program improves cognition significantly more than standard health advice among older adults at risk for dementia across Latin America.

Health Issues Tied to Behaviours in Intellectual Disability

People with intellectual disabilities who have physical health problems or sensory impairments face a higher risk for challenging behaviours.

Rimegepant Effective in Treatment-Resistant Migraine

Rimegepant is safe and effective in patients with migraine not responding to multiple prior preventive therapies, a real-world study shows.

Latest News

Household contacts who initiate ensitrelvir vs placebo within 72 hours of symptom onset in the index patient have lower risk of developing COVID, with no apparent safety concerns.

Recognizing the impact of comorbidities may guide patient selection and improve outcomes.

Teaching professionalism in medical school is required, but how best to do it? Move beyond a deficiency focus, experts say. Emphasize positive examples of professionalism.

Many medical schools don’t offer nationally recommended levels of paid parental leave.

The Ebola outbreak in the Democratic Republic of Congo has spread to two more northeastern provinces, Haut-Uele ⁠and Tshopo, the country's public health institute said in...

Fast-walking ‘super movers’ aged 80 years or older have about half the risk for cognitive impairment but no less Alzheimer’s disease pathology.

News All Time

Evidence for tVNS Stronger for Anxiety Than Cognition

Transcutaneous vagus nerve stimulation was associated with reduced anxiety severity but showed no significant benefit for working memory or inhibitory control in healthy adults.

Delirium After Surgery Linked to Lasting Loss of Cognition

Delirium after surgery is associated with lasting decline in cognition in older adults, and rehospitalizations may not explain this association.

RSV More Common Than hMPV in Adults With Chronic Illness

In adults with chronic underlying health conditions, respiratory syncytial virus is detected more often than human metapneumovirus, especially in inpatient settings, a meta-analysis finds.

No Gender Disparity in Deaths After Anaphylaxis

Hospital stay, hospital charges, and other secondary outcomes also were similar between male and female patients.

When AI Makes the Call, Doctors May Take the Blame

For all its promise and computational power, will AI in clinical medicine overcome physicians’ concerns?

New Artificial Neurons Cause Living Brain Cells to Fire

An array of artificial neurons printed on a flexible wafer produce spiking waveforms closely matching biological action — and drive living mouse brain cells to fire.

China Outpacing Europe in Drug Innovation, Pfizer Executive

China has pulled ahead of Europe in pharmaceutical innovation and drug development, a senior Pfizer executive ⁠said on Tuesday.

PCR Testing Finds Infections in Lung Transplant Recipients

Tests show greatest value when used alongside imaging.

European Patient Access to New Drugs Worsens

Patient access to new medicines is worsening across Europe, the region's main pharmaceuticals industry ⁠lobby group said.

Wrist Air Samplers Detect Virus Exposure in Kids With Asthma

Devices may inform disease prevention strategies by providing community-level data.

Colistin MIC Affects Outcomes in Gram-Negative Infections

In carbapenem-resistant gram-negative infections caused by pathogens for which the colistin MIC is 2 mg/L, the colistin-meropenem combination is linked to better clinical outcomes than colistin alone.

What 300,000 Implants Say About Light Adjustable Lens

An intraocular lens that can be adjusted after cataract surgery has better outcomes for meeting target vision than other lenses, but patient selection and involvement are key.

Parkinson’s Disease Deaths Decline Among Older US Adults

Death rates from Parkinson’s disease among US older adults decline in 2024 following a steady rise from 2014 to 2021, new data show.

Sri Lanka Battles Surge in Dengue Fever, With More Than 44,000 Cases So Far This Year

Sri Lanka is battling the worst outbreak of mosquito-borne dengue fever in years, with more than ⁠44,000 cases and 28 deaths recorded since January, an official said on...

More Than 70 Congo Medics Infected With Ebola Since Outbreak Started, WHO Says

A senior World Health Organization official said on Friday that 75 ⁠medics in the Democratic Republic of Congo had been infected with Ebola and 17 of ⁠them had died since...

US Progesterone Supplies Tighten as Menopause Treatment Demand Grows

U.S. supplies of progesterone are coming under strain, with patients, clinicians, and pharmacists reporting recent intermittent shortages of oral versions of the hormone...

Recommended News For You

Advances in "next generation" photoactive cancer therapy

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

FDA Approves New Drug Combo for RR Multiple Myeloma

Early breast cancer detection may be possible with a wearable ultrasound scanner.

Researchers investigate risk of developing multiple primary cancers after surviving bowel cancer

FDA approves rivanetin as the first-line treatment for lung cancer.

The self-sacrificing nature of breast cancer cells has been identified as a possible reason for relapse.

Recommended Articles For You

AI-Driven Chemotherapy: Transforming Cancer Care with Precision and Efficiency 

Hematologic Cytomorphology: From Microscopy to Molecular Diagnostics 

Neoadjuvant Radiotherapy & Endocrine Therapy in ER+ Breast Cancer Treatment 

Cancer Vaccines In India: The Latest Hope In The Fight Against Disease 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain

2.

In prostate cancer survivorship, sleep disturbances are underappreciated.

3.

How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma

4.

Breast Cancer Genetic Testing Need in Black Women Identified

5.

Drugmaker Pulls Trodelvy's Bladder Cancer Approval

1.

Seeing the Unseen: The Benefits of Early Stage Breast Cancer Ultrasound

2.

Exploring the Mystery of Angiokeratomas on Scrotum: Causes, Symptoms and Treatment

3.

The Ins and Outs of Glossectomy: What You Need to Know 

4.

Understanding Hidrocystoma: Symptoms, Causes, and Treatment Options 

5.

Understanding Neutrophilia: Causes, Symptoms, and Treatment Options

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment

2.

Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment

3.

Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion

4.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

5.

Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot